Strategic Global Advisors’s ResMed RMD Stock Holding History

Strategic Global Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.86M	Buy	19,794 +679	+4%	+$141K	0.55%	58
2026 Q1	$4.29M	Sell	19,115 -470	-2%	-$117K	0.69%	48
2025 Q4	$4.72M	Sell	19,585 -440	-2%	-$113K	0.73%	49
2025 Q3	$5.48M	Sell	20,025 -340	-2%	-$92.9K	0.83%	41
2025 Q2	$5.25M	Buy	20,365 +1,218	+6%	+$291K	0.86%	41
2025 Q1	$4.29M	Sell	19,147 -690	-3%	-$161K	0.85%	40
2024 Q4	$4.54M	Buy	19,837 +6,818	+52%	+$1.64M	0.83%	37
2024 Q3	$3.18M	Buy	+13,019	New	+$2.91M	0.63%	54
2021 Q1	–	Sell	-1,004	Closed	-$213K	–	179
2020 Q4	$213K	Buy	+1,004	New	+$200K	0.04%	154

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Strategic Global Advisors's RMD Position: Q2 2026 in Review

Strategic Global Advisors increased its ResMed (RMD) stake by 3.6% in Q2 2026, buying an estimated $141K and bringing the position to 19,794 shares worth $3.86M. The position accounts for 0.55% of the portfolio, ranked #58.

Strategic Global Advisors first reported a position in RMD in Q4 2020 and has held it in 9 quarters since. The position peaked at $5.48M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Strategic Global Advisors held 19,794 shares of ResMed worth $3.86M as of Q2 2026.
Strategic Global Advisors bought 679 ResMed shares in Q2 2026, an estimated $141K.
ResMed made up 0.55% of Strategic Global Advisors's portfolio in Q2 2026, its #58 holding.
Strategic Global Advisors first reported a position in ResMed in Q4 2020 and has held it in 9 quarters since.
Strategic Global Advisors's ResMed position peaked at $5.48M in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Strategic Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.